- STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugsAn ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.STAT · 16d ago↗ source
- The biggest health tech stories of 2026 — so farWe’re more than halfway through 2026, and it’s been an eventful year. Here are the five biggest developments we noticed in the first six months. Major AI companies are coming for healthcare.Endpoints · 16d ago↗ source
- STAT+: FDA finalists under reviewThree top contenders to run the FDA are under review by the White HouseSTAT · 16d ago↗ source